Advertisement: Simpsons Creative
ARM Innovation Hub
Advertisement: CJBS mid banner
Advertisement: Excalibur Healthcare mid banner
Advertisement: Mogrify mid banner
Advertisement: Kao Data Centre mid banner
Advertisement mid banner S-Tech 1
Advertisement: HCR Hewitsons mid banner
Advertisement: RSM mid banner
Barr Ellison Solicitors – commercial property
Advertisement: partnersand mid banner
Mid banner advertisement: BDO
Advertisement: Cambridge Network mid banner
Advertisement: EBCam mid banner
8 January, 2007 - 10:15 By Staff Reporter

Bio company Licht into shape following investment

Shares in Sareum rose by almost a half from a sub one penny base following news that a founding director of Mercury Asset Management had taken a ten per cent stake in the company.Sareum issued over 47 million shares at a price of 0.85 pence per share to Leonard Licht and his wife, representing an invesment of £400k. Licht is chairman of Hg Capital and a former founding director and vice chairman of Mercury.

Shares in Sareum rose 46 per cent to a shade over a penny.

The company said the funds raised from the issue would be used to provide extra working capital and for the purchase of specific capital items.

Sareum, which provides structure based drug discovery services to the pharma industry and develops early stage drug candidates for licensing, was formed by executives made redundant following the closure of Millennium Pharmaceuticals’ Cambridge facility.

Sareum's CEO, Dr Tim Mitchell said: "This significant investment by an experienced investor as Mr Licht is a positive endorsement of the long term potential value of Sareum's drug discovery business."

Licht added: "I believe Sareum to be well positioned to continue their excellent progress and ultimately occupy an important place in the pharmaceutical and biotechnology sector."

Add new comment

Newsletter Subscription

Stay informed of the latest news and features